Cargando…
Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases
Fibrosis is likely to occur in many tissues and organs to induce cicatrisation and dysfunction. The therapeutic regimens for delaying and even reversing fibrosis are quite limited at present. In nearly a decade, mesenchymal stem cells (MSCs) have been widely acknowledged as useful in treating fibrot...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334330/ https://www.ncbi.nlm.nih.gov/pubmed/34348793 http://dx.doi.org/10.1186/s13287-021-02524-1 |